Anthropic Launches In-House Drug Discovery, with Claude Doing Much of the Scientific Work
ZeroStateReflex · x · 2026-10-28
Anthropic's blog reveals its scientists have spent recent months in deep research partnerships with six organizations developing new medicines, and have begun drug discovery efforts of its own — including programs for rare childhood forms of muscular dystrophy where Claude handles much of the scientific and operational work. The post shares early results on how Claude supports multiple stages of drug development and where this fits into Anthropic's life sciences ambitions.
More from AGI Musings
- Nathan Young Asks Why AI Cyber-Risk Demos Are Obviously Unacceptable — NathanpmYoung · 2026-10-28
- Bill Gates predicts many people will reject AI and choose to 'live like the Amish' — Polymarket · 2026-10-28
- Neuroscientist Anil Seth checks in from Asilomar 2026, the storied AI safety venue — prof_kamilov · 2026-10-28
- Report breakdown: Claude sent zero emails in "one-person biotech," founder sent 12 after edits — faraz0x · 2026-10-28
- Silicon Valley influencer lists 39 Agent-era startup ideas: stop building software — FinanceYF5 · 2026-10-28
- When AI agents can do everything, picking what's worth doing is the hard part — bilawalsidhu · 2026-10-28